4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000950170-25-111529
10% owner sold 188,094 shares at an average $39.47 ($7,423,920)
From the SEC's structured data for this filing
Trades in this filing
Versant Venture Capital VI, L.P. · 10% owner
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-22 | Sale : show line 1 in the form | −20,493 | $40.03 | $820,329 | 1,379,727 | D |
| 2025-08-22 | Sale : show line 2 in the form | −10,076 | $40.03 | $403,339 | 952,802 | I |
| 2025-08-22 | Sale : show line 3 in the form | −5,668 | $40.59 | $230,064 | 1,374,059 | D |
| 2025-08-22 | Sale : show line 4 in the form | −2,809 | $40.59 | $114,017 | 949,993 | I |
| 2025-08-25 | Sale : show line 5 in the form | −50,270 | $39.53 | $1,986,947 | 1,323,789 | D |
| 2025-08-25 | Sale : show line 6 in the form | −24,760 | $39.53 | $978,651 | 925,233 | I |
| 2025-08-25 | Sale : show line 7 in the form | −2,149 | $39.92 | $85,791 | 1,321,640 | D |
| 2025-08-25 | Sale : show line 8 in the form | −1,058 | $39.92 | $42,237 | 924,175 | I |
| Open-market sales · 188,094 sh · avg $39.47 · $7,423,920 | ||||||
Loading xslF345X05/ownership.xml…